Halozyme Therapeutics shares owned by AMI Asset Management Corporation
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by AMI Asset Management Corporation
from 13F filings
Historical chart of AMI Asset Management Corporation investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by AMI Asset Management Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Halozyme Therapeutics by AMI Asset Management Corporation
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $5.6M | 137k | 40.68 |
2023-12-31 | $5.3M | 143k | 36.96 |
2023-09-30 | $5.7M | 148k | 38.20 |
2023-06-30 | $5.5M | 152k | 36.07 |
2023-03-31 | $5.6M | 146k | 38.19 |
2022-12-31 | $7.1M | 126k | 56.90 |
2022-09-30 | $5.0M | 126k | 39.54 |
2022-06-30 | $8.6M | 195k | 44.00 |
2022-03-31 | $9.9M | 249k | 39.88 |
2021-12-31 | $9.5M | 236k | 40.21 |
2021-09-30 | $11M | 259k | 40.68 |
2021-06-30 | $11M | 250k | 45.41 |
2021-03-31 | $10M | 247k | 41.69 |
2020-12-31 | $11M | 246k | 42.71 |
2020-09-30 | $14M | 518k | 26.28 |
2020-06-30 | $14M | 526k | 26.81 |
More positions owned by AMI Asset Management Corporation
View all positions for AMI Asset Management Corporation